Pacira Pharmaceuticals buy Needham & Company LLC
Start price
31.07.24
/
50%
€19.40
Target price
31.07.25
€39.65
Performance (%)
-1.55%
Price
30.07.24
€17.90
Summary
This prediction is currently active. With a performance of -1.55%, the BUY prediction for Pacira Pharmaceuticals by Needham___Company_LL is down slightly. This prediction currently runs until 31.07.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | -1.55% |
iShares Core DAX® | 0.786% |
iShares Nasdaq 100 | 1.855% |
iShares Nikkei 225® | 3.947% |
iShares S&P 500 | 1.787% |
Comments by Needham___Company_LL for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $43.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.07.24
02.07.24
€40.02
02.07.25
02.07.25
-9.91%
30.07.24
30.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.60
08.05.24
08.05.24
€39.99
08.05.25
08.05.25
-30.08%
30.07.24
30.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€25.80
09.04.24
09.04.24
€41.35
09.04.25
09.04.25
-27.91%
30.07.24
30.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
01.03.24
01.03.24
€41.61
01.03.25
01.03.25
-30.60%
30.07.24
30.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€33.40
03.08.23
03.08.23
€47.53
03.08.24
03.08.24
-44.31%
30.07.24
30.07.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€41.00
20.04.23
20.04.23
€54.71
20.04.24
20.04.24
-40.98%
21.04.24
21.04.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€40.40
28.02.23
28.02.23
€56.63
28.02.24
28.02.24
-32.18%
29.02.24
29.02.24